This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC. Fakomatozy. In: Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC, Eds. Dermatologia. Lublin, Poland: Czelej. 2002; 793-797.Braun-FalcoOPlewigGWolffHHBurgdorfWHC.FakomatozyBraun-FalcoOPlewigGWolffHHBurgdorfWHCDermatologiaLublin, PolandCzelej2002793797Search in Google Scholar
Sabol Z, Kipke-Sabol L. Neurofibromatosis type 1 (von Recklinghausen disease or peripheral neurofibromatosis): From phenotype to gene. Lijec Vjesn. 2005; 127(11-12): 303-311.SabolZKipke-SabolL.Neurofibromatosis type 1 (von Recklinghausen disease or peripheral neurofibromatosis): From phenotype to geneLijec Vjesn200512711-12303311Search in Google Scholar
Abramowicz A, Gos M. Neurofibromin in neurofibromatosis type 1 - Mutations in NF1gene as a cause of disease. Dev Period Med. 2014; 18(3): 297-306.AbramowiczAGosM.Neurofibromin in neurofibromatosis type 1 - Mutations in NF1gene as a cause of diseaseDev Period Med2014183297306Search in Google Scholar
Shofty B, Constantini S, Ben-Shachar S. Advances in molecular diagnosis of neurofibromatosis type 1. Semin Pediatr Neurol. 2015; 22(4): 234-239.ShoftyBConstantiniSBen-ShacharS.Advances in molecular diagnosis of neurofibromatosis type 1Semin Pediatr Neurol201522423423910.1016/j.spen.2015.10.007Search in Google Scholar
Ferner RE. Neurofibromatosis 1. In: Ferner RE, Huson SM, Evans DGR, Eds. Neurofibromatoses in Clinical Practice. London, UK: Springer-Verlag. 2011; 27-30.FernerRE.Neurofibromatosis 1FernerREHusonSMEvansDGRNeurofibromatoses in Clinical PracticeLondon, UKSpringer-Verlag2011273010.1007/978-0-85729-629-0Search in Google Scholar
Rasmussen S, Friedman JM. NF1 gene and neurofi-bromatosis 1. Am J Epidemiol. 2000; 151(1): 33-40.RasmussenSFriedmanJM.NF1 gene and neurofi-bromatosis 1Am J Epidemiol20001511334010.1093/oxfordjournals.aje.a010118Search in Google Scholar
Bunin GR, Needle M, Riccardi VM. Paternal age and sporadic neurofibromatosis 1: A case-control study and consideration of the methodologic issues. Genet Epidemiol. 1997; 14(5): 1507-1516.BuninGRNeedleMRiccardiVM.Paternal age and sporadic neurofibromatosis 1: A case-control study and consideration of the methodologic issuesGenet Epidemiol19971451507151610.1002/(SICI)1098-2272(1997)14:5<507::AID-GEPI5>3.0.CO;2-YSearch in Google Scholar
Laycock-van Spyk S, Thomas N, Cooper DN, Upadhyaya M. Neurofibromatosis type 1-associated tumours: Their somatic mutational spectrum and pathogenesis. Hum Genomics. 2011; 5(6): 623-690.Laycock-van SpykSThomasNCooperDNUpadhyayaM.Neurofibromatosis type 1-associated tumours: Their somatic mutational spectrum and pathogenesisHum Genomics20115662369010.1186/1479-7364-5-6-623Search in Google Scholar
Yap YS, McPherson JR, Ong CK, Rozen SG, Teh BT, Lee AS, et al. The NF1 gene revisited - From bench to bedside. Oncotarget. 2014; 5(15): 5873-5892.YapYSMcPhersonJROngCKRozenSGTehBTLeeASet al.The NF1 gene revisited - From bench to bedsideOncotarget20145155873589210.18632/oncotarget.2194Search in Google Scholar
Brems H, Beert E, de Ravel T, Legius E. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol. 2009; 10(5): 508-515.BremsHBeertEde RavelTLegiusE.Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1Lancet Oncol200910550851510.1016/S1470-2045(09)70033-6Search in Google Scholar
Venturin M, Guarnieri P, Natacci F, Stabile M, Tenconi R, Clementi M, et al. Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2. J Med Genet. 2004; 41(1): 35-41.VenturinMGuarnieriPNatacciFStabileMTenconiRClementiMet al.Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2J Med Genet2004411354110.1136/jmg.2003.014761Search in Google Scholar
Pasmant E, de Saint-Trivier A, Laurendeau I, Dieux-Coeslier A, Parfait B, Vidaud M, et al. Characterization of a 7.6-Mb germline deletion encompassing the NF1 locus and about a hundred genes in an NF1 contiguous gene syndrome patient. Eur J Hum Genet. 2008; 16(12): 1459-1466.PasmantEde Saint-TrivierALaurendeauIDieux-CoeslierAParfaitBVidaudMet al.Characterization of a 7.6-Mb germline deletion encompassing the NF1 locus and about a hundred genes in an NF1 contiguous gene syndrome patientEur J Hum Genet200816121459146610.1038/ejhg.2008.134Search in Google Scholar
Sharif S, Upadhyaya M, Ferner R, Majounie E, Shenton A, Baser M, et al. A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations. J Med Genet. 2011; 48(4): 256-260.SharifSUpadhyayaMFernerRMajounieEShentonABaserMet al.A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlationsJ Med Genet201148425626010.1136/jmg.2010.081760Search in Google Scholar
Upadhyaya M, Huson SM, Davies M, Thomas N, Chuzhanova N, Giovannini S, et al. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet. 2007; 80(1): 140-151.UpadhyayaMHusonSMDaviesMThomasNChuzhanovaNGiovanniniSet al.An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972delAAT): evidence of a clinically significant NF1 genotype-phenotype correlationAm J Hum Genet200780114015110.1086/510781178532117160901Search in Google Scholar
Rojnueangnit K, Xie J, Gomes A, Sharp A, Callens T, Chen Y, et al. High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg 1809: Genotype-phenotype correlation. Hum Mutat. 2015; 36(11): 1052-1063.RojnueangnitKXieJGomesASharpACallensTChenYet al.High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg 1809: Genotype-phenotype correlationHum Mutat201536111052106310.1002/humu.22832504960926178382Search in Google Scholar
Pinna V, Lanari V, Daniele P, Consoli F, Agolini E, Margiotti K, et al. p.Arg1809Cys Substitution in neu-rofibromin is associated with a distinctive NF1 phenotype without neurofibromas. Eur J Hum Genet. 2015; 23(8): 1068-1071.PinnaVLanariVDanielePConsoliFAgoliniEMargiottiKet al.p.Arg1809Cys Substitution in neu-rofibromin is associated with a distinctive NF1 phenotype without neurofibromasEur J Hum Genet20152381068107110.1038/ejhg.2014.243479510325370043Search in Google Scholar
Kehrer-Sawatzki H. Neurofibromatosis type 1 without neurofibromas: Genotype-phenotype correlations in NF1. Hum Mutat. 2015; 36(11): doi: 10.1002/humu.22669.Kehrer-SawatzkiH.Neurofibromatosis type 1 without neurofibromas: Genotype-phenotype correlations in NF1Hum Mutat20153611doi10.1002/humu.2266926457592Open DOISearch in Google Scholar
Santoro C, Maietta A, Giugliano T, Melis D, Perrotta S, Nigro V, et al. Arg(1809) Substitution in neurofibromin: Further evidence of a genotype-phenotype correlation in neurofibromatosis type 1. Eur J Hum Genet. 2015; 23(11): 1460-1461.SantoroCMaiettaAGiuglianoTMelisDPerrottaSNigroVet al.Arg(1809) Substitution in neurofibromin: Further evidence of a genotype-phenotype correlation in neurofibromatosis type 1Eur J Hum Genet201523111460146110.1038/ejhg.2015.93461347325966637Search in Google Scholar
Bayliss S, Mallory F, Bree A, Chern P. Dermatologia pediatryczna. In: Bayliss S, Mallory F, Bree A, Chern P, Eds. Diagnostyka i Leczenie. Lublin, Poland: Czelej. 2007; 387-389.BaylissSMalloryFBreeAChernP.Dermatologia pediatrycznaBaylissSMalloryFBreeAChernPDiagnostyka i LeczenieLublin, PolandCzelej2007387389Search in Google Scholar
Baran E. Nowotwory skóry, klinika, patologia, leczenie. In: Baran E, Ed. Lódz, Poland: Galaktyka. 2008; 195-197.BaranE.Nowotwory skóry, klinika, patologia, leczenieBaranELódz, PolandGalaktyka2008195197Search in Google Scholar
Sumner K, Crockett DK, Muram T, Mallempati K, Best H, Mao R. The SPRED1 variants repository for Legius syndrome. G3 (Bethesda). 2011; 1(6): 451-456.SumnerKCrockettDKMuramTMallempatiKBestHMaoR.The SPRED1 variants repository for Legius syndromeG3 (Bethesda)20111645145610.1534/g3.111.000687327616722384355Search in Google Scholar
Lodish MB, Stratakis CA. Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes. Best Pract Res Clin Endocrinol Metab. 2010; 24(3): 439-449.LodishMBStratakisCA.Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromesBest Pract Res Clin Endocrinol Metab201024343944910.1016/j.beem.2010.02.002293906120833335Search in Google Scholar
